The 2025 results demonstrate Paysign’s expanding presence across the healthcare ecosystem. Substantial growth in patient and client savings highlights the advanced efficacy of the company’s solutions ...
The impact of neighborhood socioeconomic deprivation on clinical outcomes for locally advanced and metastatic hepatocellular carcinoma: An incidence-based retrospective cohort study. This is an ASCO ...
Prescription costs and coverage hurdles are increasing, leading patients to act as their own payers in a fragmented system. Despite $5 billion annual investment in patient assistance programs, less ...
Gemtesa’s manufacturer (Urovant Sciences) provides the Gemtesa Simple Savings Program. This is a financial assistance plan aimed at making Gemtesa (vibegron) — a treatment for overactive bladder in ...
Even when Americans have health insurance, they can have a hard time affording the drugs they’ve been prescribed.
Prescription costs strain millions of households, forcing difficult choices between health and finances. Fortunately, ...
Former OptimizeRX CEO Brings Extensive Digital Health and Pharmaceutical Patient Assistance Expertise to AI-Driven Healthcare Financing Company NEW YORK--(BUSINESS WIRE)-- Paynela, a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback